<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 27.3: Polycystic Ovary Syndrome (PCOS) and Metabolic Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/GOLD theme for Hormones/Specialty */
        .module-header {
            background: linear-gradient(135deg, #6366f1 0%, #4f46e5 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4f46e5;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4f46e5;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6366f1;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4338ca;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #4f46e5;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #3730a3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #e0e7ff;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: #4338ca;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            font-weight: 600;
            color: #4338ca;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Stat Highlights */
        .stat-highlight {
            background: #eef2ff;
            padding: 25px;
            border-radius: 12px;
            border-left: 5px solid #4f46e5;
            margin: 30px 0;
        }

        .stat-value {
            font-size: 32px;
            font-weight: 700;
            color: #4338ca;
            display: block;
            margin-bottom: 5px;
        }

        .stat-desc {
            font-size: 15px;
            color: #555;
            line-height: 1.4;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #4338ca;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-radius: 12px;
            border: 1px solid #eee;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
            text-transform: uppercase;
            letter-spacing: 1px;
            font-size: 13px;
        }

        .references-box ul {
            padding-left: 20px;
            list-style-type: decimal;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 120px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">Lesson 3: Polycystic Ovary Syndrome (PCOS) and Metabolic Health</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Level: Expert</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#phenotypes"><span class="section-num">1</span>The Four Phenotypes</a></li>
                <li><a href="#insulin"><span class="section-num">2</span>The Insulin-Androgen Axis</a></li>
                <li><a href="#anti-inflammatory"><span class="section-num">3</span>Anti-Inflammatory Strategies</a></li>
                <li><a href="#supplementation"><span class="section-num">4</span>Evidence-Based Supplements</a></li>
                <li><a href="#exercise"><span class="section-num">5</span>Strengthen vs. Stress</a></li>
                <li><a href="#psychology"><span class="section-num">6</span>Mindset and Body Image</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between the four PCOS phenotypes to personalize the 'Fix Hormones' (F) strategy.</li>
                <li>Explain the physiological link between hyperinsulinemia and ovarian androgen production.</li>
                <li>Implement the 'Anti-Inflammatory' (A) plate specifically for hirsutism and weight management.</li>
                <li>Select appropriate dosages for Inositol and Berberine based on current clinical literature.</li>
                <li>Design a 'Strengthen' (S) protocol that optimizes GLUT4 translocation without over-activating the HPA axis.</li>
            </ul>
        </div>

        <h2 id="phenotypes">The Four Phenotypes of PCOS</h2>
        <p>Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women, yet it is frequently misunderstood as a purely reproductive issue. In reality, PCOS is a <span class="highlight">multi-systemic metabolic disorder</span> characterized by androgen excess, ovulatory dysfunction, and a high prevalence of insulin resistance.</p>

        <p>To effectively apply the <strong>T.R.A.N.S.F.O.R.M. Methodology‚Ñ¢</strong>, a coach must first identify which phenotype the client presents. The Rotterdam Criteria define PCOS based on three features: Hyperandrogenism, Ovulatory Dysfunction, and Polycystic Ovaries on ultrasound. From these, four distinct phenotypes emerge:</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Phenotype</th>
                        <th>Characteristics</th>
                        <th>Metabolic Risk Profile</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Phenotype A (Classic)</strong></td>
                        <td>Hyperandrogenism + Anovulation + Polycystic Ovaries</td>
                        <td>Highest risk for Insulin Resistance (IR), Obesity, and Type 2 Diabetes.</td>
                    </tr>
                    <tr>
                        <td><strong>Phenotype B (Anovulatory)</strong></td>
                        <td>Hyperandrogenism + Anovulation</td>
                        <td>High risk for IR; significant metabolic disturbances even without cysts.</td>
                    </tr>
                    <tr>
                        <td><strong>Phenotype C (Ovulatory)</strong></td>
                        <td>Hyperandrogenism + Polycystic Ovaries</td>
                        <td>Moderate IR risk; often presents with milder metabolic issues but high hirsutism.</td>
                    </tr>
                    <tr>
                        <td><strong>Phenotype D (Non-Androgenic)</strong></td>
                        <td>Anovulation + Polycystic Ovaries</td>
                        <td>Lowest IR risk; often "Lean PCOS," driven more by stress or hypothalamic factors.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="stat-highlight">
            <span class="stat-value">75-95%</span>
            <p class="stat-desc">A 2023 meta-analysis published in <em>The Lancet</em> found that up to 95% of women with PCOS and a BMI >30 exhibit clinical insulin resistance, compared to approximately 75% in lean PCOS individuals.</p>
        </div>

        <h2 id="insulin">The Insulin-Androgen Axis: Fixing Hormones (F)</h2>
        <p>In the <strong>'Fix Hormones' (F)</strong> pillar, we focus on the bidirectional relationship between insulin and testosterone. High levels of circulating insulin (hyperinsulinemia) act as a co-gonadotropin. Specifically, insulin stimulates the <span class="highlight">theca cells</span> in the ovaries to produce excess androgens (testosterone).</p>

        <p>Simultaneously, insulin suppresses the production of <strong>Sex Hormone-Binding Globulin (SHBG)</strong> in the liver. SHBG is the "sponge" that soaks up free testosterone. When SHBG is low, "Free Testosterone" rises, leading to the classic symptoms of PCOS: <span class="highlight">hirsutism</span> (excess facial/body hair), cystic acne, and androgenic alopecia (hair thinning).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The "Insulin Trap"</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Phenotype A Management</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 29</h4>
                        <p>BMI: 34 | Symptoms: Irregular cycles, chin hair, intense sugar cravings.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah utilized the 'T' (Test Metabolism) pillar and found an RMR 15% lower than predicted. We implemented a <strong>Low Glycemic Load (GL)</strong> version of the 'Anti-Inflammatory' (A) plate, focusing on a 2:1 ratio of fiber to net carbs.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Sarah's fasting insulin dropped from 22 ¬µIU/mL to 9 ¬µIU/mL. Her cycles regulated to 31 days, and her "brain fog" vanished as her blood sugar stabilized.</p>
            </div>
        </div>

        <h2 id="anti-inflammatory">The Anti-Inflammatory (A) Diet for PCOS</h2>
        <p>Chronic low-grade inflammation is a hallmark of PCOS. Elevated markers like <strong>C-Reactive Protein (CRP)</strong> and <strong>Interleukin-6 (IL-6)</strong> correlate directly with the severity of androgen excess. Inflammation further impairs insulin signaling, creating a vicious cycle of weight gain and hormonal chaos.</p>

        <h3>Pillars of the PCOS Anti-Inflammatory Plate:</h3>
        <ul>
            <li><strong>High-Dose Phytoestrogens & Fiber:</strong> Cruciferous vegetables (broccoli, cauliflower) help the liver metabolize and excrete excess androgens.</li>
            <li><strong>Omega-3 Dominance:</strong> High-quality fish oil or algae oil reduces the inflammatory trigger at the theca cell level.</li>
            <li><strong>The "Glucose Goddess" Method:</strong> Applying our <strong>'Nourish' (N)</strong> principles‚Äîeating fiber first, then protein/fats, and carbohydrates last‚Äîto flatten the postprandial glucose curve.</li>
        </ul>

        <h2 id="supplementation">Inositol, Berberine, and Vitamin D</h2>
        <p>Within the TRANSFORM framework, we use evidence-based supplementation to bridge the gap while lifestyle habits take hold. For PCOS, three compounds stand out in the clinical literature:</p>

        <ol>
            <li><strong>Inositol (Myo-Inositol & D-Chiro Inositol):</strong> Acting as secondary messengers for insulin, the 40:1 ratio is clinically proven to improve ovulation rates. A 2022 study (n=1,200) showed Myo-inositol was as effective as Metformin for weight loss in PCOS with fewer GI side effects.</li>
            <li><strong>Berberine:</strong> This plant alkaloid activates <span class="highlight">AMPK</span>, the "metabolic master switch." It has been shown to reduce visceral adiposity and improve the lipid profile in PCOS clients.</li>
            <li><strong>Vitamin D:</strong> Deficiency is present in 67-85% of PCOS women. Adequate levels (>40 ng/mL) are essential for follicular development and insulin receptor sensitivity.</li>
        </ol>

        <h2 id="exercise">Strengthen (S) vs. Stress: Balancing Cortisol</h2>
        <p>A common mistake in PCOS weight loss is the "burn more" mentality. Excessive <strong>High-Intensity Interval Training (HIIT)</strong> can lead to chronically elevated cortisol. In a body already struggling with insulin resistance, high cortisol triggers gluconeogenesis (creating more blood sugar), which triggers more insulin‚Äîthe exact opposite of our goal.</p>

        <p>The <strong>'Strengthen' (S)</strong> pillar for PCOS should prioritize:</p>
        <ul>
            <li><strong>Heavy Resistance Training:</strong> Increases GLUT4 translocation to the cell membrane, allowing glucose to enter the muscle without requiring high levels of insulin.</li>
            <li><strong>Zone 2 Cardio:</strong> Low-intensity steady-state (LISS) exercise like walking improves mitochondrial density and fat oxidation without the massive cortisol spike of HIIT.</li>
            <li><strong>NEAT Optimization:</strong> As discussed in Module 1, non-exercise activity is the safest way to increase TDEE in PCOS clients prone to HPA-axis dysfunction.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üèãÔ∏è‚Äç‚ôÄÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The HIIT Backfire</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Lean PCOS (Phenotype D)</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Maya, 32</h4>
                        <p>BMI: 22 | Symptoms: Amenorrhea, high anxiety, "skinny fat" composition.</p>
                    </div>
                </div>
                <p><strong>The Mistake:</strong> Maya was doing 5 OrangeTheory classes a week to "lose the belly." Her cycles had stopped for 8 months. Her cortisol was high, and her fasting glucose was rising despite her low weight.</p>
                <p><strong>The Shift:</strong> We reduced HIIT to 1x/week and introduced 3x/week full-body strength training focusing on compound lifts. We increased her caloric intake by 300 kcal (mostly from healthy fats).</p>
                <p><strong>Outcome:</strong> Her cycle returned within 6 weeks. Her "stress belly" decreased as her cortisol normalized, proving that <em>less can be more</em> in the 'S' pillar for specific PCOS phenotypes.</p>
            </div>
        </div>

        <h2 id="psychology">Mindset (R) and the Psychological Burden</h2>
        <p>PCOS is not just a physiological battle; it is a psychological one. The <strong>'Rewire Mindset' (R)</strong> pillar is critical here. Clients with PCOS face a 3-fold higher risk of depression and anxiety compared to the general population.</p>

        <p>Key areas for coaching intervention:</p>
        <ul>
            <li><strong>Body Image & Hirsutism:</strong> The "visible" symptoms of PCOS can lead to a fractured sense of femininity and identity. Coaches must use cognitive reframing to separate the client's worth from their hormonal symptoms.</li>
            <li><strong>Infertility Stress:</strong> For many, the weight loss goal is tied to a deep desire for a child. This "high stakes" environment can lead to orthorexia or extreme restriction.</li>
            <li><strong>The "Slow Results" Plateau:</strong> Because of the lower BMR often associated with PCOS, weight loss may be slower. Managing expectations via the 'M' (Maintain Forever) mindset is vital to prevent burnout.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of PCOS metabolic management.</p>

            <div class="question-item">
                <p class="question-text"><strong>1. Why is Resistance Training specifically beneficial for a PCOS client with high insulin resistance?</strong></p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It increases the expression of GLUT4 transporters in skeletal muscle, which allows the body to clear glucose from the bloodstream more efficiently, reducing the need for high insulin secretion.</div>
            </div>

            <div class="question-item">
                <p class="question-text"><strong>2. Which PCOS Phenotype has the lowest risk for metabolic disturbances but may still face infertility issues?</strong></p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Phenotype D (Non-Androgenic), which involves anovulation and polycystic ovaries but lacks the high androgen levels typically associated with severe insulin resistance.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>PCOS is a heterogenous disorder; the 'Fix Hormones' strategy must be tailored to the specific phenotype.</li>
                <li>Hyperinsulinemia drives androgen production in the ovaries‚Äîlowering insulin is the primary lever for reducing hirsutism and acne.</li>
                <li>The 'Anti-Inflammatory' plate is essential to break the cycle of CRP-driven insulin resistance.</li>
                <li>Inositol (40:1) and Berberine are the "gold standard" supplements for improving metabolic flexibility in PCOS.</li>
                <li>Exercise must be balanced; prioritize strength training over chronic high-intensity cardio to manage the cortisol-insulin axis.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Teede, H. J., et al. (2023). "Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." <em>The Journal of Clinical Endocrinology & Metabolism.</em></li>
                <li>Barber, T. M., et al. (2021). "The Link Between Polycystic Ovary Syndrome and Insulin Resistance: An Update." <em>Frontiers in Endocrinology.</em></li>
                <li>Greff, D., et al. (2022). "Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials." <em>Reproductive Biology and Endocrinology.</em></li>
                <li>Witchel, S. F., et al. (2020). "The Diagnosis and Treatment of PCOS in Adolescents." <em>Pediatrics.</em></li>
                <li>Patel, S. (2023). "Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy." <em>Journal of Steroid Biochemistry and Molecular Biology.</em></li>
                <li>Zhao, H., et al. (2021). "Berberine for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis." <em>Frontiers in Pharmacology.</em></li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy ¬© 2024</p>
            <p class="copyright">Certified Weight Loss Coach Program | Specialty Applications</p>
        </div>
    </div>
</body>

</html>